Pickering Grant

CHIEF EXECUTIVE OFFICER, DirectorVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Jul 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
8
7 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2026Option exercise(M)16K$2.03$33K469K
Jul 27, 2026Sell(S)12K$55.52$654K458K
Jul 27, 2026Sell(S)4K$55.93$247K453K
Jul 27, 2026Sell(S)756$55.52$42K133K
Jul 27, 2026Sell(S)244$55.96$14K133K
Jul 27, 2026Sell(S)622$55.54$35K134K
Jul 27, 2026Sell(S)378$55.91$21K133K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2026Option exercise(M)16K$0137K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001258693-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.